METASTASIS
Clinical trials for METASTASIS explained in plain language.
Never miss a new study
Get alerted when new METASTASIS trials appear
Sign up with your email to follow new studies for METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo takes aim at KRAS-Mutant lung cancer
Disease control Not yet recruitingThis Phase 2 trial tests whether combining two oral drugs, luvometinib and anlotinib, can shrink tumors in people with KRAS-mutated non-small cell lung cancer that has spread and stopped responding to prior treatment. About 48 adults will receive different dose combinations. The …
Matched conditions: METASTASIS
Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Surgery plus drugs may extend life in advanced liver cancer
Disease control Not yet recruitingThis study looks at whether surgically removing the main liver tumor, followed by standard immune-based drug therapy, can help people with liver cancer that has spread to other organs live longer. About 280 adults with resectable liver tumors and at least one metastasis will be r…
Matched conditions: METASTASIS
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC